Completed Infection & Immunity Genetics & Molecular Biology

Challenging trypanosome antigenic variation paradigms using natural systems

In plain English

AI plain-English summary

African trypanosomes—parasites that cause sleeping sickness in humans and nagana in cattle—are masters of disguise, constantly swapping their surface proteins to outrun the immune system. This project will track how that disguise changes over time and across different tissues, moving beyond the standard lab mouse model to study the parasites in their natural cattle hosts. Current understanding of antigenic variation comes almost entirely from a single parasite species in mice, leaving major gaps about how real infections persist in livestock. The researchers will quantify how the parasite’s antigen repertoire shifts during early versus chronic infection, and how it differs between the bloodstream and other tissues. They will also test whether molecular regulators identified in mice control the same processes in cattle-infective species. If successful, this work will produce mathematical models that explain antigenic variation in clinically relevant infections, not just lab-adapted ones. That could eventually inform vaccine design or drug strategies for African trypanosomiasis, a disease that devastates livestock and threatens human health across sub-Saharan Africa. For now, the research is fundamental science—building a more realistic picture of how these parasites survive—but that picture is a necessary step toward practical control.

View original technical description
Antigenic variation (AV) is a common mechanism used by pathogens to evade host immunity and ensure infection chronicity. Recently the capacity to study AV at a molecular and population-level has expanded through systems level approaches. However, there is urgent need to challenge existing paradigms by assessing temporal (early vs. chronic infection) and spatial (tissue compartment) influences on the pathogen antigen repertoire, as well as pathogen genotype and host context. Here, we will quantitate and derive models to parameterize antigen diversity and infection chronicity in African trypanosomes. These are an exemplar of AV where population-scale antigen mRNA sequencing is tractable and underlying molecular regulators of infection are identified and manipulable. Critically, we will extend the trypanosome AV paradigm beyond the limited infection model commonly used to date, i.e. Trypanosoma brucei in mice. Thus, we will (i) quantitate the contributors to AV in chronic bovine infections for the clinically-relevant pathogens T. congolense and T. vivax, relating this to conventional infections in mice (ii) determine the contribution of identified molecular regulators of AV, parasite development and tissue compartmentation, and (iii) use the derived information to build mathematical models to interpret and unify molecular and population-level understanding of AV in these clinically-relevant infections.

View the original record at the funder ↗

Researchers

Keith Matthews (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Variant antigen profiling: a novel genomic tool for diagnosis and surveillance of animal African trypanosomiasis.
Phylogenetic modelling of host-pathogen co-evolution
New approaches to a livestock trypanosomiasis vaccine: targeting the bite-site by immunization with novel metacyclic-stage parasite antigens
The molecular basis and evolution of host-parasite interactions in African trypanosomes
Dissecting the molecular basis of single gene choice in African trypanosomes

Original classification

Collaborative Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.